← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2016Last known activity
Feb 28, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 7 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT06257212Lead sponsorPhase 4Feb 28, 2024
- NCT06257212Sponsor investigatorPhase 4Feb 28, 2024
- NCT05921448Lead sponsorEarly Phase 1Jan 1, 2024
- NCT05921448Overall official - principal investigatorEarly Phase 1Jan 1, 2024
- NCT04538976Lead sponsorPhase 4Nov 1, 2020
- NCT04481555Lead sponsorPhase 4Sep 1, 2020
- NCT04322396Lead sponsorPhase 2Apr 6, 2020
- NCT03262142Reponsible party - principal investigatorPhase 4Jan 10, 2018
- NCT03262142Study directorPhase 4Jan 10, 2018
- NCT03262142Lead sponsorPhase 4Jan 10, 2018
- NCT02857842Lead sponsorPhase 4Aug 1, 2016
- NCT02857842Reponsible party - principal investigatorPhase 4Aug 1, 2016
Details
- Last known activity
- Feb 28, 2024